143 related articles for article (PubMed ID: 30336489)
1. C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma.
Suner A; Carr BI; Akkiz H; Karakülah G; Üsküdar O; Yalçın K; Kuran S; Tokat Y; Yilmaz S; Özakyol A; Tokmak S; Ballı T; Yücesoy M; Bahçeci Hİ; Ülkü A; Akçam T; Polat KY; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Demir A; Delik A; Arslan B; Doran F; Altıntaş E; Temel T; Bektaş A
Oncology; 2019; 96(1):25-32. PubMed ID: 30336489
[TBL] [Abstract][Full Text] [Related]
2. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
Yi X; Yu S; Bao Y
Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics.
Suner A; Carr BI; Akkiz H; Uskudar O; Kuran S; Tokat Y; Tokmak S; Ballı T; Ulku A; AkCam T; Delik A; Arslan B; Doran F; YalCın K; Ekinci N; Yilmaz S; Ozakyol A; Yücesoy M; BahCeci HI; Polat KY; Şimsek H; Ormeci N; Sonsuz A; Demir M; KılıC M; Uygun A; Demir A; Altıntas E; Karakulah G; Temel T; Bektas A
J Transl Sci; 2019 Jun; 5(3):. PubMed ID: 30662766
[TBL] [Abstract][Full Text] [Related]
5. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
[TBL] [Abstract][Full Text] [Related]
6. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
[TBL] [Abstract][Full Text] [Related]
7. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
[TBL] [Abstract][Full Text] [Related]
8. Role of serum C-reactive protein as a marker of hepatocellular carcinoma in patients with cirrhosis.
Lin ZY; Wang LY; Yu ML; Chen SC; Chuang WL; Hsieh MY; Tsai JF; Chang WY
J Gastroenterol Hepatol; 2000 Apr; 15(4):417-21. PubMed ID: 10824887
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma.
Hu J; Wang N; Yang Y; Ma L; Han R; Zhang W; Yan C; Zheng Y; Wang X
BMC Gastroenterol; 2018 Dec; 18(1):186. PubMed ID: 30545306
[TBL] [Abstract][Full Text] [Related]
10. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.
Shindoh J; Sugawara Y; Nagata R; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Tanaka T; Kokudo N
Transpl Int; 2014 Apr; 27(4):391-8. PubMed ID: 24472068
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Pre-Operative Platelet to Lymphocyte Ratio in Patients with Resected Primary Hepatocellular Carcinoma.
Dong L; Bai K; Cao Y; Huang Q; Lv L; Jiang Y
Clin Lab; 2016 Nov; 62(11):2191-2196. PubMed ID: 28164677
[TBL] [Abstract][Full Text] [Related]
12. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
13. Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio.
Xia W; Ke Q; Guo H; Wang W; Zhang M; Shen Y; Wu J; Xu X; Yan S; Yu J; Zhang M; Zheng S
BMC Cancer; 2017 Jan; 17(1):14. PubMed ID: 28056901
[TBL] [Abstract][Full Text] [Related]
14. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
[TBL] [Abstract][Full Text] [Related]
16. A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
Zhu L; Li T; Ma X; Qiu Y; Ma X; Lin Y; Han L; Qin C
Sci Rep; 2017 Aug; 7(1):8954. PubMed ID: 28827721
[TBL] [Abstract][Full Text] [Related]
17. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
[TBL] [Abstract][Full Text] [Related]
18. Performance of Alpha Fetoprotein in Combination with Alpha-1-acid Glycoprotein for Diagnosis of Hepatocellular Carcinoma Among Liver Cirrhosis Patients.
Gani RA; Suryamin M; Hasan I; Lesmana CR; Sanityoso A
Acta Med Indones; 2015 Jul; 47(3):216-22. PubMed ID: 26586387
[TBL] [Abstract][Full Text] [Related]
19. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.
Li X; Chen ZH; Xing YF; Wang TT; Wu DH; Wen JY; Chen J; Lin Q; Dong M; Wei L; Ruan DY; Lin ZX; Wu XY; Ma XK
Tumour Biol; 2015 Apr; 36(4):2263-9. PubMed ID: 25409616
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.
Akkiz H; Carr BI; Yalçın K K; Guerra V; Kuran S; Altıntaş E; Üsküdar O; Karaoğullarından Ü; Özakyol A; Tokmak S; Yücesoy M; Bahçeci Hİ; Ülkü A; Akçam T; Yalçın Polat K; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Ballı T; Demir A; Arslan B; Doran F
Oncology; 2018; 94(2):116-124. PubMed ID: 29207378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
